All the Active Ingredient Drugs
Topoisomerase I Inhibitor. Irinotecan HCl Trihydrate 20 mg/ml. GLASS VIAL(Concent. for sol. for IV infus.): 1×5,15, 25 ml. Dosage must be ajust. individ.
For the tmt. of patients with metastat. colorect. canc.: In comb.with 5-fluorouracil & folinic acid in pts. without prior chemother. for metastat. dis.
As a single agent in pts. who have failed an establish. 5-fluorouracil contain. tmt regimen.
For the tmt. of pts. with small cell lung canc.
For the tmt. of pts. with gastric canc.
C/I: Hypersens. Chron. inflamm. bowel dis. and/or bowel obstruct. Pregn. and lact. Bilirubin > 3 times the ULN. Severe bone marrow fail. WHO performance status > 2. Concomit. use with St John's Wort.
Topisomerase 1 inhibitor. Irinotecan HCl Trihydrate 20mg/ml. GLASS VIAL (Concent. for sol. for infus.):1× 5, 15, 25ml
Dosage must be ajust. individ.
For the tmt. of pts. with metast. colorec. cancer: In comb. with 5-fluorouracil and folinic acid in pts. without prior chemother. for metastat. dis. As a single agent in pts. who have failed an established 5-fluorouracil contain. tmt. regimen.
For tmt. of pts. with small cell lung cancer.
For the tmt. of pts. with gastr. cancer.
Irinotecan in comb. with leucovorin,
Oxaliplatin and 5-fluorouracil, for the 1st -line tmt. of pts. with metastat. pancreat. adenocarcinoma. metastat. pancreat. adenocarcinoma.
C/I: Hypersens.